Latest Minimaze procedure Stories
MINNEAPOLIS, Aug. 18 /PRNewswire/ -- Atritech, Inc. today announced the filing of its Pre-Market Approval Application (PMA) to the Food and Drug Administration (FDA). The PMA contains the results of the PROTECT AF Clinical Trial which began enrollment in early 2005. PROTECT AF evaluated the WATCHMAN(R) Left Atrial Appendage (LAA) Closure Technology versus the current standard of care, warfarin, in patients with non-valvular atrial fibrillation at risk of stroke. The trial enrolled 800...
MONTREAL, June 27 /PRNewswire-FirstCall/ -- CryoCath(R) Technologies Inc., the global leader in cryotherapy products to treat cardiac arrhythmias, today announced the introduction of Arctic Front(R) in Italy, Belgium and Spain. Arctic Front, the Company's lead product for the treatment of paroxysmal atrial fibrillation (PAF), is a unique cryoablation balloon catheter that allows physicians to safely and effectively isolate all four pulmonary veins for the treatment of PAF. "The introduction...
On Tuesday, July 24 at 4 PM (PST), Sutter Health in Sacramento, California, will broadcast a totally thoracoscopic (TT) epicardial surgical ablation procedure for the treatment of atrial fibrillation (AF) on www.OR-Live.com, featuring James Longoria, MD. This novel approach uses bilateral working ports to access the key anatomy necessary to achieve all goals of the procedure. The procedure includes pulmonary vein (Antrum) isolation, electrophysiologic testing and ablation of the ganglionated...
